HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David P Ryan Selected Research

Doxorubicin (Adriamycin)

10/2004Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors.
1/2004A phase II study of docetaxel in patients with metastatic carcinoid tumors.
3/2002A phase I clinical trial of sequentially administered doxorubicin and topotecan in refractory solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David P Ryan Research Topics

Disease

114Neoplasms (Cancer)
05/2024 - 01/2002
38Adenocarcinoma
11/2023 - 01/2005
37Pancreatic Neoplasms (Pancreatic Cancer)
05/2024 - 01/2002
33Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 09/2002
18Rectal Neoplasms (Rectal Cancer)
04/2022 - 02/2004
14Hepatocellular Carcinoma (Hepatoma)
01/2019 - 06/2002
11Neoplasm Metastasis (Metastasis)
11/2022 - 06/2006
9Cholangiocarcinoma
05/2024 - 01/2012
8Anus Neoplasms (Anal Cancer)
12/2020 - 04/2003
8Carcinoma (Carcinomatosis)
12/2020 - 02/2004
8Neutropenia
10/2016 - 04/2006
8Diarrhea
11/2015 - 01/2003
8Neuroendocrine Tumors (Neuroendocrine Tumor)
09/2013 - 01/2006
6Fatigue
10/2020 - 04/2004
6Fibrosis (Cirrhosis)
01/2017 - 12/2013
5Gastrointestinal Neoplasms (Gastrointestinal Cancer)
04/2023 - 01/2012
5Disease Progression
01/2023 - 02/2002
5Thrombocytopenia (Thrombopenia)
06/2009 - 03/2002
5Carcinoid Tumor (Carcinoid)
01/2009 - 01/2004
5Nausea
12/2006 - 01/2003
4Liver Diseases (Liver Disease)
04/2020 - 12/2013
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2019 - 01/2012
4Vomiting
12/2006 - 04/2004
3Biliary Tract Neoplasms (Biliary Tract Cancer)
12/2020 - 02/2008
3Esophageal Neoplasms (Esophageal Cancer)
02/2019 - 03/2002
3Breast Neoplasms (Breast Cancer)
01/2019 - 01/2003
3Lung Neoplasms (Lung Cancer)
01/2019 - 09/2005
3Peritoneal Neoplasms
02/2015 - 09/2013
3Hyperglycemia
11/2011 - 04/2004
3Colonic Neoplasms (Colon Cancer)
09/2010 - 09/2002
2Lymphopenia (Lymphocytopenia)
05/2024 - 11/2011
2Inflammation (Inflammations)
04/2024 - 04/2003
2Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2014
2Brain Neoplasms (Brain Tumor)
01/2021 - 01/2019
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 10/2020
2Melanoma (Melanoma, Malignant)
01/2021 - 12/2015
2Exanthema (Rash)
10/2020 - 11/2011
2Circulating Neoplastic Cells
01/2020 - 01/2017
2Carcinogenesis
01/2019 - 03/2012
2Hypoxia (Hypoxemia)
05/2015 - 11/2011

Drug/Important Bio-Agent (IBA)

23Fluorouracil (Carac)FDA LinkGeneric
10/2022 - 02/2002
17Irinotecan (Camptosar)FDA LinkGeneric
10/2022 - 09/2005
15folfirinoxIBA
01/2023 - 01/2013
15GemcitabineFDA Link
01/2020 - 01/2002
13Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2022 - 01/2003
11Protons (Proton)IBA
05/2024 - 08/2007
11Leucovorin (Folinic Acid)FDA Link
10/2022 - 01/2003
11Capecitabine (Xeloda)FDA Link
07/2019 - 01/2003
10Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2005
9RNA (Ribonucleic Acid)IBA
04/2024 - 07/2012
9ErbB Receptors (EGF Receptor)IBA
02/2014 - 09/2005
8Bevacizumab (Avastin)FDA Link
03/2015 - 02/2004
7Cetuximab (Erbitux)FDA Link
02/2014 - 05/2006
7Tyrosine Kinase InhibitorsIBA
03/2013 - 09/2005
5EverolimusFDA Link
09/2013 - 01/2009
5Gefitinib (Iressa)FDA Link
10/2007 - 09/2005
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2005
4Circulating Tumor DNAIBA
10/2021 - 12/2015
4LigandsIBA
10/2020 - 08/2007
4130-nm albumin-bound paclitaxelIBA
01/2020 - 12/2017
4Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2019 - 04/2003
3Enterotoxin ReceptorsIBA
04/2023 - 10/2016
3Immunoconjugates (Immunoconjugate)IBA
04/2023 - 10/2016
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2023 - 11/2011
3AntigensIBA
01/2022 - 01/2005
3Paclitaxel (Taxol)FDA LinkGeneric
12/2021 - 01/2007
3Immune Checkpoint InhibitorsIBA
11/2021 - 10/2019
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2020 - 08/2007
3Monoclonal AntibodiesIBA
10/2020 - 01/2012
3Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
09/2015 - 01/2012
3Temozolomide (Temodar)FDA LinkGeneric
09/2013 - 01/2006
3Cisplatin (Platino)FDA LinkGeneric
01/2013 - 06/2006
3Sunitinib (Sutent)FDA Link
02/2011 - 07/2008
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2008 - 09/2002
3Bortezomib (Velcade)FDA Link
05/2008 - 11/2006
3Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2007 - 04/2006
3Docetaxel (Taxotere)FDA Link
07/2006 - 01/2002
3Thalidomide (Thalomid)FDA Link
02/2006 - 06/2005
3Doxorubicin (Adriamycin)FDA LinkGeneric
10/2004 - 03/2002
2Losartan (Cozaar)FDA LinkGeneric
01/2023 - 07/2019
2NucleosidesIBA
01/2022 - 11/2003
2Cell-Free Nucleic AcidsIBA
01/2019 - 01/2017
2ProdrugsIBA
05/2015 - 01/2003

Therapy/Procedure

56Therapeutics
11/2023 - 01/2002
44Drug Therapy (Chemotherapy)
01/2023 - 01/2002
28Radiotherapy
05/2024 - 04/2003
24Neoadjuvant Therapy
11/2023 - 08/2007
7Chemoradiotherapy
01/2022 - 07/2010
6Proton Therapy
05/2024 - 01/2011
6Intravenous Infusions
07/2006 - 10/2002
5Immunotherapy
11/2021 - 01/2005
5Combination Drug Therapy (Combination Chemotherapy)
12/2019 - 01/2004
5Adjuvant Chemotherapy
01/2018 - 01/2008
4Hyperthermic Intraperitoneal Chemotherapy
01/2021 - 09/2013
3Combined Modality Therapy
02/2019 - 12/2011
3Drug Tapering
12/2011 - 01/2002
2Precision Medicine
01/2022 - 01/2020
2Palliative Care (Palliative Therapy)
01/2020 - 03/2017
2Length of Stay
01/2019 - 11/2014
2Subcutaneous Injections
12/2017 - 08/2006